Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Vaccines
|
November 26, 2024
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
NPJ Vaccines
|
November 15, 2022
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Ioannis Sitaras, Henning Jacobsen, Melissa M Higdon, et al.
NPJ Vaccines
|
October 20, 2023
Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
Vaccines
|
October 27, 2022
Post-Vaccination Neutralization Responses to Omicron Sub-Variants
Henning Jacobsen, Maeva Katzmarzyk, Melissa M Higdon, et al.
Frontiers in Immunology
|
August 22, 2022
Post-vaccination T cell immunity to omicron
Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, et al.
Pediatric Radiology
|
March 11, 2021
Training physicians in India to interpret pediatric chest radiographs according to World Health Organization research methodology
Eric D McCollum, Melissa M Higdon, Nicholas S S Fancourt, et al.
Vaccine
|
May 20, 2022
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Daniel R Feikin, Laith J Abu-Raddad, Nick Andrews, et al.
Vaccines
|
June 24, 2022
Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera
Henning Jacobsen, Ioannis Sitaras, Marley Jurgensmeyer, et al.
Vaccine
|
February 16, 2023
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
Daniel R Feikin, Melissa M Higdon, Nick Andrews, et al.
Nature Communications
|
October 13, 2025
Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines
Martina Pesce, Daniel R Feikin, Melissa M Higdon, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Vaccines
|
November 26, 2024
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
NPJ Vaccines
|
November 15, 2022
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Ioannis Sitaras, Henning Jacobsen, Melissa M Higdon, et al.
NPJ Vaccines
|
October 20, 2023
Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
Vaccines
|
October 27, 2022
Post-Vaccination Neutralization Responses to Omicron Sub-Variants
Henning Jacobsen, Maeva Katzmarzyk, Melissa M Higdon, et al.
Frontiers in Immunology
|
August 22, 2022
Post-vaccination T cell immunity to omicron
Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, et al.
Pediatric Radiology
|
March 11, 2021
Training physicians in India to interpret pediatric chest radiographs according to World Health Organization research methodology
Eric D McCollum, Melissa M Higdon, Nicholas S S Fancourt, et al.
Vaccine
|
May 20, 2022
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Daniel R Feikin, Laith J Abu-Raddad, Nick Andrews, et al.
Vaccines
|
June 24, 2022
Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera
Henning Jacobsen, Ioannis Sitaras, Marley Jurgensmeyer, et al.
Vaccine
|
February 16, 2023
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
Daniel R Feikin, Melissa M Higdon, Nick Andrews, et al.
Nature Communications
|
October 13, 2025
Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines
Martina Pesce, Daniel R Feikin, Melissa M Higdon, et al.
Page
of 5